Anticancer agents encompass a diverse range of therapies designed to combat cancer by targeting specific aspects of tumor growth and metastasis. These agents can include chemotherapy drugs, targeted therapies, immunotherapies, and hormone therapies. Chemotherapy drugs, such as cisplatin and paclitaxel, work by interfering with the cell division process, effectively killing rapidly dividing cancer cells. Targeted therapies, like monoclonal antibodies and small molecule inhibitors, aim to disrupt specific molecules or pathways crucial for cancer cell survival and proliferation. Immunotherapies harness the power of the immune system to recognize and eliminate cancer cells. Hormone therapies are effective against hormone-sensitive cancers by blocking hormone receptors or reducing hormone production. The development of novel anticancer agents continues to revolutionize cancer treatment, offering hope for improved outcomes and enhanced quality of life for patients.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States